Table III.
N = 0 | N = 1 | N = 2 | N = 3 | N > 3 | ||
---|---|---|---|---|---|---|
IG protocol | Referencing scheme | Number of patients (%) | ||||
NIG | 11 (18.3) | 13 (21.7) | 14 (23.3) | 4 (6.7%) | 18 (30.0) | |
R1 | 13 (21.7) | 10 (16.7) | 15 (25.0) | 6 (10.0) | 16 (26.7) | |
IG-1 | R3 | 15 (25.0) | 11 (18.3) | 12 (20.0) | 5 (8.3) | 17 (28.3) |
R5 | 17 (28.3) | 10 (16.7) | 13 (21.7) | 4 (6.7) | 16 (26.7) | |
R1 | 23 (38.3) | 11 (18.3) | 9 (15.0) | 4 (6.7) | 13 (21.7) | |
IG-2 | R3 | 26 (43.3) | 10 (16.7) | 10 (16.7) | 2 (3.3) | 12 (20.0) |
R5 | 25 (41.7) | 12 (20.0) | 9 (15.0) | 2 (3.3) | 12 (20.0) | |
R1 | 17 (28.3) | 13 (21.7) | 10 (16.7) | 5 (8.3) | 15 (25.0) | |
IG-3 | R3 | 19 (31.7) | 12 (20.0) | 12 (20.0) | 3 (5.0) | 14 (23.3) |
R5 | 20 (33.3) | 13 (21.7) | 11 (18.3) | 2 (3.3) | 14 (23.3) | |
R1 | 10 (16.7) | 12 (20.0) | 11 (18.3) | 8 (13.3) | 19 (31.7) | |
IG-4 | R3 | 11 (18.3) | 13 (21.7) | 13 (21.7) | 6 (10.0) | 17 (28.3) |
R5 | 12 (20.0) | 14 (23.3) | 11 (18.3) | 6 (10.0) | 17 (28.3) |